IRIS UniCatt

Mantini, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.492
EU - Europa 3.797
AS - Asia 3.036
SA - Sud America 568
AF - Africa 86
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 12.012
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.351
DE - Germania 1.527
SG - Singapore 1.411
CN - Cina 738
SE - Svezia 603
BR - Brasile 471
FR - Francia 323
IT - Italia 307
UA - Ucraina 278
VN - Vietnam 223
GB - Regno Unito 182
IN - India 169
IE - Irlanda 141
ID - Indonesia 100
CA - Canada 90
PL - Polonia 79
RU - Federazione Russa 79
FI - Finlandia 70
JP - Giappone 67
TR - Turchia 66
BE - Belgio 43
HK - Hong Kong 40
BD - Bangladesh 39
AR - Argentina 34
CZ - Repubblica Ceca 31
IQ - Iraq 31
NL - Olanda 26
MX - Messico 23
ZA - Sudafrica 21
ES - Italia 20
SA - Arabia Saudita 20
EC - Ecuador 17
AU - Australia 16
AT - Austria 15
CI - Costa d'Avorio 15
IR - Iran 14
JO - Giordania 14
UZ - Uzbekistan 14
CL - Cile 12
MA - Marocco 12
CH - Svizzera 11
TN - Tunisia 11
BZ - Belize 10
PK - Pakistan 10
PT - Portogallo 10
VE - Venezuela 10
AZ - Azerbaigian 9
PH - Filippine 9
CO - Colombia 8
EU - Europa 8
KE - Kenya 8
LT - Lituania 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
KR - Corea 7
DK - Danimarca 5
DZ - Algeria 5
IL - Israele 5
KZ - Kazakistan 5
NO - Norvegia 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
HU - Ungheria 4
JM - Giamaica 4
LB - Libano 4
MY - Malesia 4
NG - Nigeria 4
NP - Nepal 4
RO - Romania 4
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
EE - Estonia 2
HN - Honduras 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
PS - Palestinian Territory 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
Totale 11.996
Salva come PNG Salva come JPEG
Città #
Singapore 761
Chandler 666
San Jose 445
Ashburn 412
Jacksonville 156
Beijing 153
Ann Arbor 145
Dublin 140
San Mateo 138
Nanjing 107
The Dalles 106
Nürnberg 100
Dearborn 98
Houston 96
Jakarta 90
New York 85
Woodbridge 83
Lauterbourg 81
Wilmington 81
Los Angeles 74
Ho Chi Minh City 73
Boston 69
Munich 68
Frankfurt am Main 66
Warsaw 62
Hanoi 58
Redwood City 57
Tokyo 57
Marseille 53
São Paulo 52
Milan 48
Bremen 46
Nanchang 46
Cattolica 45
Fairfield 45
Izmir 44
Moscow 44
Princeton 44
Brussels 42
Redmond 38
Hefei 37
Hong Kong 37
Lawrence 37
Dallas 35
Rome 33
Toronto 32
Buffalo 31
Santa Clara 30
Paris 29
Seattle 29
Chicago 22
Hebei 22
Leawood 22
North York 21
Kunming 20
Shanghai 20
Tianjin 19
Hangzhou 18
Jiaxing 18
Shenyang 18
Helsinki 17
Boardman 16
London 16
Mountain View 16
Abidjan 15
Atlanta 15
Guangzhou 15
Amman 14
Brasília 14
Düsseldorf 14
Hyderabad 14
Stockholm 14
Albuquerque 13
Brooklyn 13
Orem 13
Rio de Janeiro 13
San Diego 13
San Francisco 13
Washington 13
Zhengzhou 13
Amsterdam 12
Enterprise 12
Phoenix 12
Tashkent 12
Andover 11
Changsha 11
Ottawa 11
Belize City 10
Da Nang 10
Baghdad 9
Falls Church 9
Fremont 9
Las Vegas 9
University Park 9
Baku 8
Belo Horizonte 8
Bexley 8
Cambridge 8
Cape Town 8
Denver 8
Totale 6.082
Salva come PNG Salva come JPEG
Nome #
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 311
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 287
Pros-IT CNR: an Italian prostate cancer monitoring project 282
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 279
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 234
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 228
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 226
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 213
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 210
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 208
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 204
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. 202
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 201
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 196
Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases 194
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 192
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 192
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 190
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study 187
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 185
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 176
Radiotherapy vs Follow up in the treatment of pathological stage Ia and Ib non small cell lung cancer. Early stopped analysis of a randomized controlled study. 173
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 173
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 169
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 167
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial 165
Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome 165
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 164
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 164
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study 163
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 162
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 162
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 156
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 152
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy. 152
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 151
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 151
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 148
Role of radiotherapy in the treatment of fibrosarcoma of the spermatic cord: a case report and review of the literature 146
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 140
Targeted "bone-seeking" radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis. 139
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 138
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 138
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 134
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 133
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 129
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 127
Can automation in radiotherapy reduce costs? 126
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 125
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 125
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 125
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 124
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 120
OncotypeDX (R) predictive nomogram for recurrence score output: A machine learning system based on quantitative immunochemistry analysis-ADAPTED01 118
Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial 117
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 117
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology 114
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 113
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 110
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 110
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: Low-dose fractionated radiotherapy with concurrent chemotherapy 107
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 106
BIT-ART: Multicentric comparison of HDR-brachytherapy, intensity-modulated radiotherapy and tomotherapy for advanced radiotherapy in prostate cancer 103
Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy 102
Breakthrough pain management in patients undergoing radiotherapy: A national survey on behalf of the Palliative and Supportive Care Study Group 101
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 101
Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: Final results of a phase I/II trial 100
Locoregional pain treatment. Troubles and prospectives: antalgic radiotherapy 99
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 98
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 95
Adaptive optimization by 6 DOF robotic couch in prostate volumetric IMRT treatment: Rototranslational shift and dosimetric consequences 95
Radiotherapy plus GnRH analogue versus high dose bicalutamide: A case control study 92
Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma 91
776 poster THE PRELIMINARY RESULTS OF PHASE II STUDY: NEOADJUVANT CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR BREAST CANCER 84
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 82
Impact of dose and volume on radiation-induced mucositis 75
External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study 73
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study 69
Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: An Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study 68
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 67
Split course concomitant radiochemotherapy followed by brachytherapy boost in the exclusive treatment of the anal canal cancer 55
Spider: Managing clinical data of cancer patients treated through a multidisciplinary approach by a palm based system 51
Preoperative radiotherapy in gastric cancer: CTV definition for conformal therapy according to tumor location 51
Chemoradiation with raltitrexed (TOMUDEX) in preoperative treatment of stage II-III resectable rectal cancer: A phase II study 50
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure 40
Quality handbook in radiotherapy: personal experience 37
Totale 12.194
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.442
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022849 77 57 16 58 52 45 27 134 34 67 132 150
2022/20231.770 254 250 149 303 102 208 88 126 203 13 47 27
2023/2024724 33 207 20 69 29 95 16 55 11 22 78 89
2024/20251.541 49 49 118 55 149 41 26 72 250 151 324 257
2025/20263.556 592 96 188 345 672 178 638 195 273 244 108 27
Totale 12.194